William W. Ericson, Director, 10% Owner at Adamas Pharmaceuticals Inc (ADMS), sold 1,643 shares at $18.04 ($30K) on 2015-05-18, disclosed to the SEC on 2015-05-20.
Scheduled sale ($30k) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ADMS | BUY | 2016-09-16 | $2.1M | — | Filing → |
| ADMS | BUY | 2016-09-14 | $2.6M | — | Filing → |
| ADMS | BUY | 2016-09-09 | $1.9M | — | Filing → |